Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -90,570 | -165,563 | -36,292 | -30,422 | -45,406 |
| Depreciation Amortization | 76,906 | 311,471 | 167,934 | 111,457 | 55,067 |
| Income taxes - deferred | -47,695 | -65,561 | -35,158 | -5,362 | -2,657 |
| Accounts receivable | -94,377 | -68,271 | -142,448 | -83,932 | -69,838 |
| Accounts payable and accrued liabilities | 36,078 | 32,065 | 49,695 | 42,278 | 52,856 |
| Other Working Capital | 45,993 | 135,767 | 20,746 | -48,794 | 9,900 |
| Other Operating Activity | 98,471 | 189,548 | 205,794 | 116,259 | 54,259 |
| Operating Cash Flow | $24,806 | $369,456 | $230,271 | $101,484 | $54,181 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,423 | -15,725 | -14,616 | -12,776 | -7,525 |
| Net Acquisitions | N/A | -1,354,921 | -520,405 | -520,405 | N/A |
| Other Investing Activity | 0 | 0 | -3,411 | -1,309 | -515,732 |
| Investing Cash Flow | $-1,423 | $-1,370,646 | $-538,432 | $-534,490 | $-523,257 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 847,768 | 656,190 | N/A | N/A | N/A |
| Debt Repayment | -772,750 | -4,000 | -3,000 | -2,000 | -1,000 |
| Common Stock Issued | 544 | 10,423 | 6,619 | 4,893 | 919 |
| Other Financing Activity | -4,450 | -5,539 | -5,309 | -4,734 | -4,185 |
| Financing Cash Flow | $71,112 | $657,074 | $-1,690 | $-1,841 | $-4,266 |
| Exchange Rate Effect | -298 | -1,210 | -462 | -244 | -421 |
| Beginning Cash Position | 516,150 | 861,476 | 859,616 | 859,616 | 859,616 |
| End Cash Position | 610,347 | 516,150 | 549,303 | 424,525 | 385,853 |
| Net Cash Flow | $94,197 | $-345,326 | $-310,313 | $-435,091 | $-473,763 |
| Free Cash Flow | |||||
| Operating Cash Flow | 24,806 | 369,456 | 230,271 | 101,484 | 54,181 |
| Capital Expenditure | -1,423 | -15,725 | -14,616 | -12,776 | -7,525 |
| Free Cash Flow | 23,383 | 353,731 | 215,655 | 88,708 | 46,656 |